Literature DB >> 30572777

The utility of fetal fibronectin in asymptomatic singleton and twin pregnancies with a cervical length ≤ 10 mm.

Noelia Zork1, Moti Gulersen2, Anne Mardy3, Caroline Pessel4, Sara Brubaker5, Joy Vink1, Cynthia Gyamfi-Bannerman1, Cande V Ananth1,6.   

Abstract

Objective: To examine the utility of fetal fibronectin (fFN) for predicting spontaneous preterm birth (PTB) in asymptomatic women with a cervical length (CL) ≤10 mm compared to those with a CL 11-25 mm.
Methods: Data was collected on all women with nonanomalous singleton and twin gestations who underwent transvaginal CL at a single institution between 2009 and 2012. Women with an incidental short cervix (CL ≤ 25 mm) between 22 and 32 weeks who had an fFN result within 7 days thereafter were included. Indicated preterm deliveries at <14 days of fFN, women who underwent cerclage placement, and terminations of pregnancy were excluded. The primary outcome was spontaneous PTB within 7 and 14 days of the fFN. Sensitivity, specificity, and positive (PPV) and negative predictive value (NPV) of fFN for a CL ≤ 10 mm was calculated for singletons and twins and compared to those with a CL 11-25 mm.
Results: Of the 213 women included, 117 (54.9%) were singletons and 96 (45%) were twins. Baseline characteristics were similar between those with a CL ≤ 10 mm and with a CL 11-25 mm in both singletons and twins. The NPV of fFN for delivery within 7 days in singletons and twins with a CL ≤ 10 mm was 100%, similar to those with a CL 11-25 mm (93-100%). The NPV of fFN for delivery within 14 days in singletons and twins with a CL ≤ 10 mm remained high (87.5-100%) when compared to those with a CL 11-25 mm (93-100%). The PPV of fFN for delivery within 7 and 14 days in both singletons and twins with a CL ≤ 10 mm was low (10-25%) and similar to those with a CL 11-25 mm (7.1-24.4%).Conclusions: The NPV of fFN in asymptomatic singleton and twin pregnancies with a CL ≤ 10 mm is high and comparable to the NPV of fFN in women with a longer CL. Routine fFN collection in this select population should be considered as it may avoid unnecessary and costly admissions, as well as assist with timing of antenatal corticosteroids.

Entities:  

Keywords:  Cervical length; fetal fibronectin; preterm birth; short cervix

Mesh:

Substances:

Year:  2019        PMID: 30572777      PMCID: PMC6625907          DOI: 10.1080/14767058.2018.1562541

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  29 in total

1.  Association of Temporal Changes in Gestational Age With Perinatal Mortality in the United States, 2007-2015.

Authors:  Cande V Ananth; Robert L Goldenberg; Alexander M Friedman; Anthony M Vintzileos
Journal:  JAMA Pediatr       Date:  2018-07-01       Impact factor: 16.193

Review 2.  Fetal fibronectin testing for reducing the risk of preterm birth.

Authors:  Vincenzo Berghella; Edward Hayes; John Visintine; Jason K Baxter
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

3.  Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity.

Authors:  Tracy M Adams; Wendy L Kinzler; Martin R Chavez; Melissa J Fazzari; Anthony M Vintzileos
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

4.  Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length.

Authors:  H F Andersen; C E Nugent; S D Wanty; R H Hayashi
Journal:  Am J Obstet Gynecol       Date:  1990-09       Impact factor: 8.661

Review 5.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  D Roberts; S Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

6.  The association between fetal fibronectin and spontaneous preterm birth in twin pregnancies with a shortened cervical length.

Authors:  Kathy C Matthews; Simi Gupta; Jennifer Lam-Rachlin; Daniel H Saltzman; Andrei Rebarber; Nathan S Fox
Journal:  J Matern Fetal Neonatal Med       Date:  2017-07-10

7.  Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor.

Authors:  Thomas Schmitz; Françoise Maillard; Sandrine Bessard-Bacquaert; Gilles Kayem; Yvonne Fulla; Dominique Cabrol; François Goffinet
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

8.  Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length.

Authors:  P Rozenberg; F Goffinet; L Malagrida; Y Giudicelli; M Perdu; I Houssin; I Nisand
Journal:  Am J Obstet Gynecol       Date:  1997-01       Impact factor: 8.661

9.  Routine cervical length and fetal fibronectin screening in asymptomatic twin pregnancies: is there clinical benefit?

Authors:  Shirlee Jaffe Lifshitz; Armin Razavi; Carolina Bibbo; Andrei Rebarber; Ashley S Roman; Daniel H Saltzman; Nathan S Fox
Journal:  J Matern Fetal Neonatal Med       Date:  2013-09-05

10.  Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms.

Authors:  Melanie M Plaut; Wendy Smith; Kathleen Kennedy
Journal:  Am J Obstet Gynecol       Date:  2003-06       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.